Marie Werner

Dr. Marie Werner is a board-certified Reproductive Endocrinologist and a High-complexity Clinical Laboratory Director. She completed her Reproductive Endocrinology and Infertility fellowship at RMANJ [now Everleap Fertility] in the Rutgers-Robert Wood Johnson fellowship program, where she had the privilege of training in clinical medicine, molecular genetics and embryology. Dr. Werner completed her residency in Obstetrics and Gynecology at NYU Langone Medical Center where she served as the administrative chief resident. She obtained her B.S from Boston College in 2004 and her M.D. from New Jersey Medical School in 2008.

Dr. Werner has led two large randomized control trials investigating the optimal media formulation for embryo culture and the use of next-generation sequencing for pre-implantation genetic screening of embryos. She continues to be involved in research and is interested in embryo physiology, culture and investigating techniques to determine the pre-conception reproductive competence of embryos.

Dr. Werner's areas of expertise and interest include embryo physiology, culture, and investigating techniques to determine the pre-conception reproductive competence of embryos.  She believes that the heart of reproductive medicine lies in the embryology laboratory and is proud to be part of Everleap Fertility’s center for excellence.

Accomplishments and Awards

• Clinical Assistant Professor, Department of Obstetrics and Gynecology, Thomas Jefferson University
• Clinical Associate Professor, Division of Reproductive Endocrinology, Department of Obstetrics, Gynecology and Reproductive Sciences, Rutgers-Robert Wood Johnson Medical School
• Five-Star Physicians, Suburban Life, May 2022
• Top Physicians 2022, Suburban Life, February 2022
• Top Doctors 2019, Suburban Life, August 2019
• Top Physicians in the Greater Philadelphia Area: Medicine's Finest, Suburban Life/Philadelphia Life, August 2017
• 2016 SRBT Clinical Science Award – ASRM “Targeted NGS Provides Accurate Predictions of Segmental (SEG) Aneuploidy and Prognosticates Reduced Reproductive Potential of the Human Blastocyst”
• ASRM Corporate Member Council In-training Travel Grant 2015
• Co-Investigator on “NeXgen Evaluation of the efficacy of next-generation sequencing in predicting embryonic karyotype and subsequent pregnancy outcomes in in vitro fertilization cycles (IVF)” sponsored by Ferring Pharmaceuticals 2014-2015
• Southbound Train Grant, Midwest Reproductive Symposium International 2014 & 2015